MedPath

Effect of Cash Benefits on Health Care Utilization

Not Applicable
Completed
Conditions
Health Care Utilization
Interventions
Other: Cash Benefit
Other: No Cash Benefit
Registration Number
NCT05622903
Lead Sponsor
Harvard Medical School (HMS and HSDM)
Brief Summary

Using data from the Chelsea Eats program, we propose to study a randomized controlled trial in which the City of Chelsea, Massachusetts held a lottery to allocate cash benefits to its residents for ten months during the first two years of the COVID-19 pandemic. We will analyze the impact of the cash benefit on health care utilization and health.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3615
Inclusion Criteria
  • Resident of Chelsea, Massachusetts
  • Household income at or below 30% of the U.S. Department of Housing and Urban Development's Area Median Income
Exclusion Criteria
  • See inclusion criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment GroupCash BenefitParticipants in the treatment group received up to $400 per month.
Control GroupNo Cash BenefitParticipants in the control group did not receive monthly cash benefits.
Primary Outcome Measures
NameTimeMethod
Emergency department use10 months

Count of visits to the emergency department (ED) using the electronic health record

Secondary Outcome Measures
NameTimeMethod
Blood pressure10 months

Continuous measure of blood pressure, using the latest available reading or result during trial period

Behavioral health-related ED visit10 months

Visits to the ED with a behavioral health-related diagnosis code

ED visit resulting in admission to the hospital10 months

Visits to the ED that result in a hospitalization

Potentially avoidable ED visit10 months

Visits to the ED that are potentially avoidable, categorized as avoidable according to the previously validated New York University algorithm

Outpatient service use10 months

Office visits and visits for other types of outpatient care such as imaging and procedures

Cholesterol10 months

Continuous measure of cholesterol, using the latest available reading or result during trial period

COVID vaccination10 months

Binary variable for having received at least one dose of any COVID vaccine by the end of the trial period

Hemoglobin A1c10 months

Continuous measure of diabetes, using the latest available reading or result during trial period

Weight10 months

Continuous measure of weight, using the latest available reading or result during trial period

Substance use disorder-related ED visit10 months

Visits to the ED with a substance use disorder-related diagnosis code

Trial Locations

Locations (1)

Harvard Medical School

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath